Skip to main content
Log in

Progress in secondary prevention of stroke with PROGRESS

  • Clinical Trials Report
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Collins R, Peto F, MacMahon S: Blood pressure, stroke, and coronary heart disease, part 2: short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990, 335:827–838.

    Article  PubMed  CAS  Google Scholar 

  2. Staessen JA, Wang J: Blood-pressure lowering for the secondary prevention of stroke. Lancet 2001, 358:1026–1027.

    Article  PubMed  CAS  Google Scholar 

  3. The Heart Outcomes Prevention Evaluation Study Investigators:Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145–154.

    Article  Google Scholar 

  4. Hansson L, Lindholm LH, Niskanen L, et al., and the CAPPPStudy Group: Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999, 353:611–616.

    Article  PubMed  CAS  Google Scholar 

  5. Messerli FH, Grossman E, Goldbourt U: Are β-blockers efficacious as first-line therapy for hypertension in the elderly? JAMA 1998, 279:1903–1907.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schiffrin, E.L. Progress in secondary prevention of stroke with PROGRESS. Current Science Inc 4, 39–40 (2002). https://doi.org/10.1007/s11906-002-0051-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-002-0051-0

Keywords

Navigation